TREATMENT BRIEF: Anti-Addiction Drug Shows Promise
Low-dose naltrexone (LDN) is getting a lot of attention as a treatment for fibromyalgia (FMS) and chronic fatigue syndrome (CFS or ME/CFS), as well as a host of other conditions. A normal doses, it's an anti-addiction drug, but at very low doses it acts very differently.
LDN works on the central nervous system, which is believed to be disordered in FMS and ME/CFS. It's also believed to reduce inflammation, which can be a problem in ME/CFS and with disorders that are common in people with FMS (FMS is not considered an inflammatory condition.)
An exciting thing about LDN is that it's inexpensive and already on the market. Anecdotal evidence so far is very promising, as is the first clinical trial for FMS.
Have you tried LDN? How did it work for you? Are you considering it? Leave a comment below!